MFL-23321-60521
3 vaccinations
1 coded response
22 check-ins
1 free-text entry
0 call cases
- Sex
- Female
- Age at first dose
- 36-40
- ZIP prefix
- 787 / TX
- Registered
- 2021-02-02
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Registered dependents
FCQ-50318-75512
Child or adolescent in my care · Female · 2022-06-26
FN3-15117-67549
Child or adolescent in my care · Female · 2022-07-20
KGC-30906-49048
Child or adolescent in my care · Male · 2023-01-28
Timeline
-
2021-02-02
Registered in v-safe
-
2021-02-02
Dose 1 — Pfizer-BioNTech
- 2021-02-02
- 2021-02-03
- 2021-02-04
- 2021-02-05
- 2021-02-06
- 2021-02-07
- 2021-02-08
- 2021-02-09
- 2021-02-16
-
2021-02-22
Dose 2 — Pfizer-BioNTech
- 2021-02-22
- 2021-02-24
-
2021-02-25
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Fever · Fatigue or tiredness, Abdominal pain · Be unable to workAdult check-in
- 2021-02-27
- 2021-02-28
- 2021-03-01
- 2021-03-08
- 2021-03-15
- 2021-03-22
-
2021-11-28
Dose 3 — Pfizer-BioNTech
- 2021-12-03
- 2021-12-28
-
2022-01-02
Survey response — day 35, dose 3MedDRA: Diarrhoea — Feeling: Good · Be unable to do your normal daily activitiesFree text: DiarrheaMedDRA releases: 2024-11 · check-in free text available
- 2022-03-02
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-02-02 | Pfizer-BioNTech | |
| 2 | 2021-02-22 | Pfizer-BioNTech | |
| 3 | 2021-11-28 | Pfizer-BioNTech | No |
Free text
Release 10 — day 35, dose 3
Symptoms: Diarrhea
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Diarrhoea | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release